One of the p53 targets is p21 WAF1/CIP1, the inhibitor of cell cycle phases in the G1/S and G2/M and this protein has also been reported to be upregulated as a response to nocodazole treatment in human non-small cell lung carcinoma cell-line A549 [33]. Here, TP53 is linked to non-small cell lung carcinoma.